PL2100898T3 - Sposób zatężania polipeptydu - Google Patents
Sposób zatężania polipeptyduInfo
- Publication number
- PL2100898T3 PL2100898T3 PL08166902T PL08166902T PL2100898T3 PL 2100898 T3 PL2100898 T3 PL 2100898T3 PL 08166902 T PL08166902 T PL 08166902T PL 08166902 T PL08166902 T PL 08166902T PL 2100898 T3 PL2100898 T3 PL 2100898T3
- Authority
- PL
- Poland
- Prior art keywords
- polypeptide
- concentration
- Prior art date
Links
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/45—Transferases (2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/16—Extraction; Separation; Purification by chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/34—Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/36—Extraction; Separation; Purification by a combination of two or more processes of different types
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01061—Hydroxymethylbilane synthase (2.5.1.61)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06001—Arylsulfatase (3.1.6.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01024—Alpha-mannosidase (3.2.1.24)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01046—Galactosylceramidase (3.2.1.46)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y301/00—Hydrolases acting on ester bonds (3.1)
- C12Y301/06—Sulfuric ester hydrolases (3.1.6)
- C12Y301/06008—Cerebroside-sulfatase (3.1.6.8)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA200600488 | 2006-04-04 | ||
| DKPA200600922 | 2006-07-05 | ||
| EP07711305.8A EP2004672B1 (en) | 2006-04-04 | 2007-04-04 | A process for concentration of a polypeptide |
| PCT/DK2007/000177 WO2007112757A2 (en) | 2006-04-04 | 2007-04-04 | A process for concentration of a polypeptide |
| EP08166902.0A EP2100898B1 (en) | 2006-04-04 | 2007-04-04 | A process for concentration of a polypeptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2100898T3 true PL2100898T3 (pl) | 2019-11-29 |
Family
ID=38472949
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13167428.5T PL2631242T3 (pl) | 2006-04-04 | 2007-04-04 | Sposób zatężania polipeptydu |
| PL08166902T PL2100898T3 (pl) | 2006-04-04 | 2007-04-04 | Sposób zatężania polipeptydu |
| PL13167427T PL2628746T3 (pl) | 2006-04-04 | 2007-04-04 | Sposób zatężania polipeptydu |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13167428.5T PL2631242T3 (pl) | 2006-04-04 | 2007-04-04 | Sposób zatężania polipeptydu |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13167427T PL2628746T3 (pl) | 2006-04-04 | 2007-04-04 | Sposób zatężania polipeptydu |
Country Status (20)
| Country | Link |
|---|---|
| US (6) | US20090246187A1 (pl) |
| EP (4) | EP2628746B1 (pl) |
| JP (6) | JP2009532394A (pl) |
| KR (3) | KR20150103339A (pl) |
| CN (1) | CN105233276A (pl) |
| AU (2) | AU2007234195B2 (pl) |
| BR (1) | BRPI0709737A2 (pl) |
| CA (3) | CA2644642C (pl) |
| DK (1) | DK2628746T3 (pl) |
| ES (3) | ES2744499T3 (pl) |
| HU (1) | HUE042402T2 (pl) |
| IL (4) | IL194267A (pl) |
| MX (1) | MX2008012748A (pl) |
| NO (3) | NO347673B1 (pl) |
| NZ (7) | NZ623123A (pl) |
| PL (3) | PL2631242T3 (pl) |
| PT (1) | PT2628746T (pl) |
| SI (1) | SI2628746T1 (pl) |
| WO (1) | WO2007112757A2 (pl) |
| ZA (2) | ZA200805346B (pl) |
Families Citing this family (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8536315B2 (en) | 2004-01-30 | 2013-09-17 | Shire Pharmaceuticals Ireland Limited | Production and purification of recombinant arylsulftase |
| KR20150103339A (ko) | 2006-04-04 | 2015-09-09 | 샤이어 파마슈티칼스 아일랜드 리미티드 | 폴리펩타이드의 농축 방법 |
| AU2011220163B2 (en) * | 2010-02-24 | 2015-05-28 | Chiesi Farmaceutici S.P.A. | Process for production and purification of recombinant lysosomal alpha-mannosidase |
| KR102537084B1 (ko) * | 2010-06-25 | 2023-05-26 | 샤이어 휴먼 지네틱 테라피즈 인크. | 아릴설파타제 a의 cns 전달을 위한 방법들 및 조성물들 |
| HUE031036T2 (en) | 2010-06-25 | 2017-06-28 | Shire Human Genetic Therapies | Therapeutic drug delivery to the central nervous system |
| US9320711B2 (en) | 2010-06-25 | 2016-04-26 | Shire Human Genetic Therapies, Inc. | Methods and compositions for CNS delivery of heparan N-sulfatase |
| WO2011163648A1 (en) | 2010-06-25 | 2011-12-29 | Shire Human Genetic Therapies, Inc. | Cns delivery of therapeutic agents |
| ES2625511T3 (es) | 2011-07-08 | 2017-07-19 | Shire Human Genetic Therapies, Inc. | Métodos para la purificación de arylsulfatasa A |
| EP2793922B1 (en) | 2011-12-23 | 2019-10-30 | Shire Human Genetic Therapies, Inc. | Stable formulations for cns delivery of arylsulfatase a |
| AU2013347260B2 (en) * | 2012-11-13 | 2016-07-28 | Chiesi Farmaceutici S.P.A. | Purification of recombinant human galactocerebroside beta-galactosidase (rhGALC) |
| AU2013357812B2 (en) * | 2012-12-11 | 2019-10-10 | Centogene Gmbh | Method for the diagnosis of metachromatic leukodystrophy |
| WO2014110246A1 (en) | 2013-01-09 | 2014-07-17 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
| TWI745671B (zh) | 2013-03-15 | 2021-11-11 | 美商百歐維拉提夫治療公司 | 因子ｉｘ多肽調配物 |
| CA2943034C (en) | 2014-03-24 | 2022-06-14 | Biogen Ma Inc. | Lyophilized factor ix formulations |
| JP6957738B2 (ja) * | 2017-08-31 | 2021-11-02 | グリーン・クロス・コーポレイションＧｒｅｅｎ Ｃｒｏｓｓ Ｃｏｒｐ． | スルファターゼタンパク質を精製する方法 |
| KR102290596B1 (ko) * | 2020-09-10 | 2021-08-19 | 주식회사 파이안바이오테크놀로지 | 분리된 미토콘드리아를 포함하는 주사용 조성물 및 이의 용도 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2041280A1 (en) | 1990-05-10 | 1991-11-11 | Yosuke Sawada | Arylsulfatase |
| NO960163D0 (no) | 1996-01-15 | 1996-01-15 | Thomas Berg | Mutasjonsdeteksjon av bovin |
| WO1999037325A2 (en) | 1998-01-27 | 1999-07-29 | Hemebiotech A/S | Method for treating acute intermittent porphyria (aip) and other porphyric diseases |
| RU2197500C2 (ru) * | 1998-06-09 | 2003-01-27 | Статенс Серум Институт | Способ получения иммуноглобулинов для внутривенного введения и другие иммуноглобулиновые продукты |
| US6281336B1 (en) * | 1998-06-09 | 2001-08-28 | Statens Serum Institut | Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| US6537777B1 (en) | 1998-07-27 | 2003-03-25 | Hemebiotech A/S | Human porphobilinogen deaminase sequences |
| AUPQ026799A0 (en) * | 1999-05-10 | 1999-06-03 | Csl Limited | Method of increasing protein stability by removing immunoglobulin aggregates |
| JP2003505057A (ja) * | 1999-07-27 | 2003-02-12 | ヘム−バイオテック エイ／エス | ｒｈＰＢＧＤの製造及び急性間欠性ポルフィリン症（ＡＩＰ）及び他のポルフィリン症の患者を処置するための新規な治療方法 |
| US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
| CA2429210A1 (en) | 2000-11-15 | 2002-05-23 | Jason C. Goodrick | Expression system for recombinant proteins |
| WO2002098455A2 (en) * | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human arylsulfatase a |
| WO2002099092A2 (en) | 2001-06-07 | 2002-12-12 | Hemebiotech A/S | Production of recombinant human lysosomal alpha-mannosidase |
| EP1402014A1 (en) | 2001-06-29 | 2004-03-31 | Hemebiotech A/S | A process for purification of recombinant porphobilinogen deaminase |
| US7232670B2 (en) * | 2001-09-28 | 2007-06-19 | St. Jude Children's Research Hospital | Targeting proteins to cells expressing mannose receptors via expression in insect cells |
| AU2003222568B2 (en) | 2002-01-11 | 2009-05-07 | Bioasis Technologies, Inc. | Use of P97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes |
| AU2003212912A1 (en) * | 2002-02-04 | 2003-09-02 | Millipore Corporation | Process for removing protein aggregates and virus from a protein solution |
| CH694697A5 (de) | 2004-01-29 | 2005-06-15 | Koelbl Engineering Und Consult | Gummimehl-enthaltende Elastomerlegierungen. |
| US8536315B2 (en) * | 2004-01-30 | 2013-09-17 | Shire Pharmaceuticals Ireland Limited | Production and purification of recombinant arylsulftase |
| SI1740204T1 (en) | 2004-04-01 | 2018-07-31 | Chiesi Farmaceutici S.P.A. | MEDICAL APPLICATION OF ALFA-MANOSIDES |
| US20060051347A1 (en) * | 2004-09-09 | 2006-03-09 | Winter Charles M | Process for concentration of antibodies and therapeutic products thereof |
| KR20150103339A (ko) * | 2006-04-04 | 2015-09-09 | 샤이어 파마슈티칼스 아일랜드 리미티드 | 폴리펩타이드의 농축 방법 |
-
2007
- 2007-04-04 KR KR1020157023398A patent/KR20150103339A/ko not_active Application Discontinuation
- 2007-04-04 ES ES08166902T patent/ES2744499T3/es active Active
- 2007-04-04 EP EP13167427.7A patent/EP2628746B1/en active Active
- 2007-04-04 EP EP07711305.8A patent/EP2004672B1/en active Active
- 2007-04-04 NO NO20211305A patent/NO347673B1/no unknown
- 2007-04-04 SI SI200732097T patent/SI2628746T1/sl unknown
- 2007-04-04 NZ NZ62312307A patent/NZ623123A/en unknown
- 2007-04-04 PT PT13167427T patent/PT2628746T/pt unknown
- 2007-04-04 WO PCT/DK2007/000177 patent/WO2007112757A2/en active Application Filing
- 2007-04-04 NZ NZ588903A patent/NZ588903A/xx unknown
- 2007-04-04 CA CA2644642A patent/CA2644642C/en active Active
- 2007-04-04 ES ES13167428T patent/ES2928096T3/es active Active
- 2007-04-04 CA CA2632528A patent/CA2632528C/en active Active
- 2007-04-04 NZ NZ597548A patent/NZ597548A/xx unknown
- 2007-04-04 KR KR1020087026971A patent/KR101504969B1/ko active IP Right Grant
- 2007-04-04 AU AU2007234195A patent/AU2007234195B2/en active Active
- 2007-04-04 PL PL13167428.5T patent/PL2631242T3/pl unknown
- 2007-04-04 DK DK13167427.7T patent/DK2628746T3/en active
- 2007-04-04 HU HUE13167427A patent/HUE042402T2/hu unknown
- 2007-04-04 US US12/295,848 patent/US20090246187A1/en not_active Abandoned
- 2007-04-04 CA CA2882501A patent/CA2882501C/en active Active
- 2007-04-04 NZ NZ568728A patent/NZ568728A/en unknown
- 2007-04-04 BR BRPI0709737-9A patent/BRPI0709737A2/pt not_active Application Discontinuation
- 2007-04-04 NZ NZ571610A patent/NZ571610A/en unknown
- 2007-04-04 JP JP2009503414A patent/JP2009532394A/ja active Pending
- 2007-04-04 EP EP13167428.5A patent/EP2631242B1/en active Active
- 2007-04-04 PL PL08166902T patent/PL2100898T3/pl unknown
- 2007-04-04 PL PL13167427T patent/PL2628746T3/pl unknown
- 2007-04-04 NZ NZ582045A patent/NZ582045A/en unknown
- 2007-04-04 CN CN201510510807.4A patent/CN105233276A/zh active Pending
- 2007-04-04 ES ES13167427T patent/ES2713488T3/es active Active
- 2007-04-04 EP EP08166902.0A patent/EP2100898B1/en active Active
- 2007-04-04 KR KR1020147010563A patent/KR20140057678A/ko active Application Filing
- 2007-04-04 MX MX2008012748A patent/MX2008012748A/es active IP Right Grant
- 2007-04-04 NZ NZ607595A patent/NZ607595A/en unknown
-
2008
- 2008-05-30 NO NO20082510A patent/NO20082510L/no not_active Application Discontinuation
- 2008-06-19 ZA ZA2008/05346A patent/ZA200805346B/en unknown
- 2008-09-22 IL IL194267A patent/IL194267A/en active IP Right Grant
- 2008-09-26 AU AU2008229659A patent/AU2008229659B2/en active Active
- 2008-11-07 ZA ZA2008/09540A patent/ZA200809540B/en unknown
- 2008-11-12 NO NO20084776A patent/NO346368B1/no unknown
-
2009
- 2009-07-09 JP JP2009162789A patent/JP5384232B2/ja active Active
-
2011
- 2011-03-24 IL IL211905A patent/IL211905A0/en unknown
- 2011-04-26 US US13/094,321 patent/US8809055B2/en active Active
-
2013
- 2013-06-12 JP JP2013123735A patent/JP2013236633A/ja active Pending
- 2013-10-02 JP JP2013207365A patent/JP2014058521A/ja not_active Withdrawn
- 2013-10-02 JP JP2013207384A patent/JP5878152B2/ja active Active
-
2014
- 2014-07-01 US US14/321,642 patent/US20140314735A1/en not_active Abandoned
- 2014-11-30 IL IL235982A patent/IL235982A0/en unknown
-
2015
- 2015-09-16 IL IL241654A patent/IL241654B/en active IP Right Grant
- 2015-11-16 JP JP2015223865A patent/JP2016104000A/ja active Pending
-
2016
- 2016-02-11 US US15/041,841 patent/US9713634B2/en active Active
-
2017
- 2017-03-29 US US15/473,460 patent/US20170202927A1/en not_active Abandoned
- 2017-05-03 US US15/585,916 patent/US20180289777A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL241654A0 (en) | A process for concentrating a polypeptide | |
| PL2423315T3 (pl) | Sposób osiągania lepszej ekspresji polipeptydu | |
| AP2009004746A0 (en) | Process for prepaiIrng diaminophenothiazinium compounds | |
| IL207429A0 (en) | A method of purifying a peptide | |
| IL197765A0 (en) | Methods for purification of polypeptide conjugates | |
| ZA200900836B (en) | Process for the purification of FC-fusion proteins | |
| GB0619941D0 (en) | Chemical process | |
| EP2135946A4 (en) | METHOD FOR MANUFACTURING A POLYPEPTIDE | |
| GB0619942D0 (en) | Chemical process | |
| ZA200704159B (en) | Method for analysis of pellet-cladding interaction | |
| EP2088136A4 (en) | PROCESS FOR PRODUCING HYDROXYADAMANTANE-AMINE | |
| PT2079843T (pt) | Processo para a produção de biogás | |
| IL197979A0 (en) | Method for peptide synthesis | |
| EP1995322A4 (en) | METHOD FOR CLEANING AMINO ACID | |
| GB0610387D0 (en) | Chemical process | |
| EP2045324A4 (en) | METHODS FOR PRODUCING THE N36 BINDING PEPTIDE | |
| EP1968934A4 (en) | METHOD FOR OBTAINING PURE OSELTAMIVIR | |
| EP2006302A4 (en) | PROTEIN COMPLEX AND METHOD FOR THE PRODUCTION THEREOF | |
| EP2050816A4 (en) | PROCESS FOR PRODUCING AMINO ACID | |
| EP2119772A4 (en) | PROCESS FOR MANUFACTURING TRACP5b | |
| EP1985611A4 (en) | PROCESS FOR THE PREPARATION OF O-METHYL-N-NITROISOHARNSTOFF | |
| GB2440637B (en) | Method of facilitating analysis of a peptide | |
| GB0618832D0 (en) | Chemical process | |
| GB201017988D0 (en) | Chemical process | |
| GB0610385D0 (en) | Chemical process |